"We are focused on working the maze backwards. By doing this, we can meet conventional research in the middle, thus solving this problem." - Chris Ostrowski
(PRWEB) July 20, 2015
Spring Lake, Michigan: Dr. Michael Warmoth created the Agent Z Project as a lifelong dream to rid the world of Multiple Sclerosis. Multiple Sclerosis, or M.S. , is a deteriorating neurologic disease which afflicts those in the prime of their lives. This disease affects 300,000 people in the United States and 3.5 million worldwide. Sometimes it is progressive; other times it cruelly waxes and wanes. No cause has been identified thus far. The Agent Z team believes they have identified an environmental organism that may trigger M.S. , which they refer to as Agent Z. Dr. Warmoth and his Agent Z team believe they know the switch to turn off M.S.
The Agent Z Project represents an alternate approach to standard drug discovery. Existing models attempt to minimize ongoing damage to the body. The cost of this approach runs an average of $75,000 per patient annually and the results can be mixed. Conclusively identifying the Agent Z organism would allow for vaccination to prevent the disease or prevent relapses in many cases. The cost would likely be much less.
With sufficient funding, the team plans to test a vaccine against Agent Z in mice that are prone to develop M.S. The hope is that the vaccine will allow the mice to fight off the trigger and hence not develop the disease or relapse. Positive results would then allow partnerships with biotechnology firms skilled at further vaccine development.
This approach could be a watershed moment for other diseases as well. The discovery of one autoimmune cure could lead to many others. Agent Z has evidentiary links to Type I Diabetes, Crohn’s Disease, Childhood Leukemia, and Juvenile Rheumatoid Arthritis.
Engage in the solution and change the pace of cure development by clicking here:
Agent Z How2Help- http://bit.ly/1VegqS1